Cargando…
Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer
Anaplastic Thyroid Cancer (ATC) is an aggressive malignancy with limited therapeutic options and dismal patient survival. We have previously shown MADD to be differentially overexpressed in multiple cancer histologies and to contribute to tumor cell growth and survival. Therefore, we targeted MADD b...
Autores principales: | Saini, Shikha, Sripada, Lakshmi, Tulla, Kiara, Kumar, Prabhakaran, Yue, Fei, Kunda, Nicholas, Maker, Ajay V., Prabhakar, Bellur S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374448/ https://www.ncbi.nlm.nih.gov/pubmed/30760700 http://dx.doi.org/10.1038/s41419-019-1351-5 |
Ejemplares similares
-
Therapeutic advances in anaplastic thyroid cancer: a current perspective
por: Saini, Shikha, et al.
Publicado: (2018) -
IG20/MADD Plays a Critical Role in Glucose-Induced Insulin Secretion
por: Li, Liang-cheng, et al.
Publicado: (2014) -
MADD Knock-Down Enhances Doxorubicin and TRAIL Induced Apoptosis in Breast Cancer Cells
por: Turner, Andrea, et al.
Publicado: (2013) -
Identification of a Novel OX40L(+) Dendritic Cell Subset That Selectively Expands Regulatory T cells
por: Marinelarena, Alejandra, et al.
Publicado: (2018) -
Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death
por: Qin, Jianzhong, et al.
Publicado: (2017)